In vivo Effect of Systemic pam-idronate Disodium on bo_ne Resorption in Experimental Cholesteatoma.
- Author:
Hyung Jong KIM
1
;
Jin Hwan KIM
;
Jin HU
;
Tae Hyun YOON
;
Byung Hun JUN
Author Information
1. Department of Otorhinolaryngology, College of Medicine, Hallym University, Seoul, Korea. hjk1000@www.hallym.or.kr
- Publication Type:Original Article
- Keywords:
Pamidronate disodium;
Cholesteatoma;
bone resorption;
Osteoclast
- MeSH:
Bone Resorption;
Cholesteatoma*;
Cholesteatoma, Middle Ear;
Gerbillinae;
Osteoclasts;
Temporal Bone
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
1998;41(9):1111-1117
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Bone resorption of adjacent structures in aural cholesteatoma is mostly responsible for serious complication of the disease. Recent researches have been aimed at preventing bone resorption with tools of non-surgical therapy. The effect of pam-idronate disodium on systemic bone resorption is mainly attributed by its function against osteoclast recruitment and activation. In this study, we investigated the effect of systemic pam-idronate disodium on localized osteoclastic bone resorption in experimental cholesteatoma. MATERIAL AND METHODS: Experimental cholesteatomas were induced in 40 mongolian gerbils. pam-idronate disodium (Aredia(R), Ciba-Geigy Limited)were injected subcutaneously once a week in 20 gerbils (treated group)and none were injected in the other 20 gerbils (untreated group). pam-idronate disodium were injected with a dose of 2 mg/kg in 10 of the treated group (low dose group) and with a dose of 4 mg/kg in the remainder (high dose group). Gerbils were sacrificed at 12 weeks (3 month group) or 17 weeks (4 month group) after the injection. Harvested temporal bones were examined by light microscope and transmission electron microscope. RESULTS: The clinical stage of cholesteatoma tended to be more advanced in the untreated group than in the treated group although it was not statistically significant. Scores of osteoclast number per total bone length in millimeter were lower in the treated group than in the untreated, although the percentage of surface occupied by osteoclasts per total bone surface were not different between the groups. CONCLUSION: These results will provide fundamental data for further studies on the prevention and treatment of osteoclastic bone resorption in aural cholesteatoma.
